Woodline Partners’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6M Buy
605,612
+129,657
+27% +$3M 0.05% 425
2026
Q1
$9.79M Buy
475,955
+235,866
+98% +$5.32M 0.04% 516
2025
Q4
$5.69M Buy
+240,089
New +$5.84M 0.02% 598
2023
Q4
Sell
-185,376
Closed -$4.26M 619
2023
Q3
$4.26M Buy
+185,376
New +$4.71M 0.05% 332
2023
Q2
Sell
-140,656
Closed -$3.88M 726
2023
Q1
$3.88M Buy
+140,656
New +$3.71M 0.05% 329
2022
Q2
Sell
-110,553
Closed -$2.96M 867
2022
Q1
$2.96M Sell
110,553
-32,297
-23% -$763K 0.05% 316
2021
Q4
$3.7M Sell
142,850
-66,825
-32% -$1.67M 0.05% 327
2021
Q3
$4.94M Buy
209,675
+76,925
+58% +$2.69M 0.08% 251
2021
Q2
$5.89M Buy
+132,750
New +$4.9M 0.11% 203

Other funds holding PRVA

Woodline Partners's PRVA Position: Q2 2026 in Review

Woodline Partners increased its Privia Health (PRVA) stake by 27% in Q2 2026, buying an estimated $3M and bringing the position to 605,612 shares worth $15.6M. The position accounts for 0.05% of the portfolio, ranked #425.

Woodline Partners first reported a position in PRVA in Q2 2021 and has held it in 9 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Woodline Partners held 605,612 shares of Privia Health worth $15.6M as of Q2 2026.
  • Woodline Partners bought 129,657 Privia Health shares in Q2 2026, an estimated $3M.
  • Privia Health made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #425 holding.
  • Woodline Partners first reported a position in Privia Health in Q2 2021 and has held it in 9 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.